北京百普赛斯生物科技股份有限公司申请稿

Application Proof of ACROBIOSYSTEMS CO., LTD (the “Company”)(A joint stock company incorporated in the People’s Republic of China with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “StockExchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providinginformation to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to changewhich can be material. By viewing this document, you acknowledge, accept and agree with the Company, its solesponsor, overall coordinator, advisors and members of the underwriting syndicate that: (a)this document is only for the purpose of providing information about the Company to the public in HongKong and not for any other purposes. No investment decision should be based on the information containedin this document;(b)the publication of this document or any supplemental, revised or replacement pages on the Stock Exchange’swebsite does not give rise to any obligation of the Company, its sole sponsor, overall coordinator, advisors ormembers of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction.There is no assurance that the Company will proceed with the offering;(c)the contents of this document or supplemental, revised or replacement pages may or may not be replicated infull or in part in the actual final listing document;(d)this Application Proof is not the final listing document and may be updated or revised by the Company fromtime to time in accordance with the Rules Governing the Listing of Securities on The Stock Exchange ofHong Kong Limited;(e)this document does not constitute a prospectus, offering circular, notice, circular, brochure or advertisementoffering to sell any securities to the public in any jurisdiction, nor is it an invitation to the public to makeoffers to subscribe for or purchase any securities, nor is it calculated to invite offers by the public tosubscribe for or purchase any securities;(f)this document must not be regarded as an inducement to subscribe for or purchase any securities, and nosuch inducement is intended;(g)neither the Company nor any of its affiliates, its sole sponsor, advisors or any members of its underwritingsyndicate is offering, or is soliciting offers to buy, any securities in any jurisdiction through the publicationof this document;(h)no application for the securities mentioned in this document should be made by any person nor would suchapplication be accepted;(i)the Company has not and will not register the securities referred to in this document under the United StatesSecurities Act of 1933, as amended, or any state securities laws of the United States;(j)as there may be legal restrictions on the publication of this document or dissemination of any informationcontained in this document, you agree to inform yourself about and observe any such restrictions applicableto you; and(k)the application to which this document relates has not been approved for listing and the Stock Exchange andthe Commission may accept, return or reject the application for the subject public offering and/or listing. If an offer or an invitation is made to the public in Hong Kong in due course, prospective investors arereminded to make their investment decisions solely based on the Company’s document registered with theRegistrar of Companies in Hong Kong, copies of which will be distributed to the public during the offerperiod. THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BEREAD IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. IMPORTANT If you are in any doubt about any of the contents of this document, you should obtain independent professional advice. ACROBIOSYSTEMS CO., LTD (A joint stock company incorporated in the People’s Republic of China with limited liability) [REDACTED] Number of [REDACTED] under the [REDACTED]:[REDACTED] H Shares (subject to the [REDACTED]Option)Number of [REDACTED]:[REDACTED] H Shares (subject to reallocation)Number of [REDACTED]:[REDACTED] H Shares (subject to reallocation andthe [REDACTED])Maximum [REDACTED]:HK$[REDACTED] per H Share, plus brokerage of1.0%, SFC transaction levy of 0.0027%, StockExchange trading fee of 0.00565% and AFRCtransaction levy of 0.00015% (payable in full onapplication in Hong Kong dollars and subject torefund)Nominal Value:RMB1.00 per H ShareStock Code:[•]Sole Sponsor, [REDACTED] Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take noresponsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liabilitywhatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this documen